Market Tracker

12/17 6:05pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

During the Trading Day
96.45 +4.37 / +4.75%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
96.45 0.00 / 0.00%
 
Volume: 6.0K

Today’s Trading

Previous close92.08
Today’s open92.50
Day’s range91.12 - 96.54
Volume573,234
Average volume (3 months)734,193
Market cap$7.1B
Dividend yield--
Data as of 4:00pm ET, 12/17/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-265.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book21.71

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.37+0.65%
CBSTCubist Pharmaceutica...+1.07+1.11%
ISISIsis Pharmaceuticals...+2.54+4.62%
ICLRICON PLC+0.99+1.93%
Data as of 4:04pm ET, 12/17/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts